You are here

Development of a Cytomegalovirus DNA Vaccine

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43AI058386-01
Agency Tracking Number: AI058386
Amount: $263,787.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
10390 PACIFIC CENTER COURT
SAN DIEGO, CA 92121
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 THOMAS Evans
 (858) 646-1158
 TEVANS@VICAL.COM
Business Contact
Phone: (858) 646-1108
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): The specific AIM of this Phase I SBIR proposal from Vical Incorporated is to move forward an immunotherapeutic vaccine for cytomegalovirus (CMV) from preclinical to clinical development. Vical has undertaken a program

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government